Aflibercept Versus Bevacizumab as First-Line Therapy in Age-Related Macular Degeneration.
Saved in:
| Title: | Aflibercept Versus Bevacizumab as First-Line Therapy in Age-Related Macular Degeneration. |
|---|---|
| Authors: | SALAVAT, MĂDĂLINA-CASIANA PALFI1, ȘECLĂMAN, EDWARD PAUL2, MUȘAT, ANDREEA-ALEXANDRA3, BORUGĂ, MĂDĂLINA4, PATONI, CRISTINA3,5, POPESCU, MARIUS-NICOLAE3,6, TEODORESCU, OANA ELENA7, MUȘAT, OVIDIU3,7, PATONI, STELLA IOANA POPESCU2,7 |
| Source: | Current Health Sciences Journal. Oct-Dec2023, Vol. 49 Issue 4, p503-509. 7p. |
| Database: | Academic Search Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 174745780 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Aflibercept Versus Bevacizumab as First-Line Therapy in Age-Related Macular Degeneration. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22SALAVAT%2C+MĂDĂLINA-CASIANA+PALFI%22">SALAVAT, MĂDĂLINA-CASIANA PALFI</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22ȘECLĂMAN%2C+EDWARD+PAUL%22">ȘECLĂMAN, EDWARD PAUL</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22MUȘAT%2C+ANDREEA-ALEXANDRA%22">MUȘAT, ANDREEA-ALEXANDRA</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22BORUGĂ%2C+MĂDĂLINA%22">BORUGĂ, MĂDĂLINA</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22PATONI%2C+CRISTINA%22">PATONI, CRISTINA</searchLink><relatesTo>3,5</relatesTo><br /><searchLink fieldCode="AR" term="%22POPESCU%2C+MARIUS-NICOLAE%22">POPESCU, MARIUS-NICOLAE</searchLink><relatesTo>3,6</relatesTo><br /><searchLink fieldCode="AR" term="%22TEODORESCU%2C+OANA+ELENA%22">TEODORESCU, OANA ELENA</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22MUȘAT%2C+OVIDIU%22">MUȘAT, OVIDIU</searchLink><relatesTo>3,7</relatesTo><br /><searchLink fieldCode="AR" term="%22PATONI%2C+STELLA+IOANA+POPESCU%22">PATONI, STELLA IOANA POPESCU</searchLink><relatesTo>2,7</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Current+Health+Sciences+Journal%22">Current Health Sciences Journal</searchLink>. Oct-Dec2023, Vol. 49 Issue 4, p503-509. 7p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=174745780 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.12865/CHSJ.49.03.04 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 7 StartPage: 503 Titles: – TitleFull: Aflibercept Versus Bevacizumab as First-Line Therapy in Age-Related Macular Degeneration. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: SALAVAT, MĂDĂLINA-CASIANA PALFI – PersonEntity: Name: NameFull: ȘECLĂMAN, EDWARD PAUL – PersonEntity: Name: NameFull: MUȘAT, ANDREEA-ALEXANDRA – PersonEntity: Name: NameFull: BORUGĂ, MĂDĂLINA – PersonEntity: Name: NameFull: PATONI, CRISTINA – PersonEntity: Name: NameFull: POPESCU, MARIUS-NICOLAE – PersonEntity: Name: NameFull: TEODORESCU, OANA ELENA – PersonEntity: Name: NameFull: MUȘAT, OVIDIU – PersonEntity: Name: NameFull: PATONI, STELLA IOANA POPESCU IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: Oct-Dec2023 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 20670656 Numbering: – Type: volume Value: 49 – Type: issue Value: 4 Titles: – TitleFull: Current Health Sciences Journal Type: main |
| ResultId | 1 |
